Original Research

Published on 21 Dec 2021

Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting

in Renal Pharmacology

Yueh-Ting Lee
Chien-Ning Hsu
Chung-Ming Fu
Shih-Wei Wang
Chiang-Chi Huang
Lung-Chih Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.781379

3,717 views
7 citations

Original Research

Published on 21 Dec 2021

Empagliflozin Reduces Renal Hyperfiltration in Response to Uninephrectomy, but Is Not Nephroprotective in UNx/DOCA/Salt Mouse Models

in Renal Pharmacology

Philipp Tauber
Frederick Sinha
Raffaela S. Berger
Wolfram Gronwald
Katja Dettmer
Michaela Kuhn
Maximilian Trum
Lars S. Maier
Stefan Wagner
Frank Schweda

Frontiers in Pharmacology

doi 10.3389/fphar.2021.761855

3,989 views
10 citations

Original Research

Published on 20 Dec 2021

High-Salt Attenuates the Efficacy of Dapagliflozin in Tubular Protection by Impairing Fatty Acid Metabolism in Diabetic Kidney Disease

in Renal Pharmacology

Meina Zou
Yanrong Chen
Zongji Zheng
Shuyue Sheng
Yijie Jia
Xiangyu Wang
Shijing Ren
Yanling Yang
Xiaomin Li
Wenhui Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.741087

2,907 views
7 citations

Original Research

Published on 16 Dec 2021

Immune Characteristics of IgA Nephropathy With Minimal Change Disease

in Renal Pharmacology

Huixian Li
Wanhong Lu
Haiyun Li
Xiaoling Liu
Xue Zhang
Liyi Xie
Ping Lan
Xiaoyang Yu
Yinjuan Dai
Xinfang Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2021.793511

2,910 views
3 citations

Original Research

Published on 13 Dec 2021

Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats

in Renal Pharmacology

Chunlan Ji
Yin Li
Yenan Mo
Zhaoyu Lu
Fuhua Lu
Qizhan Lin
Xusheng Liu
Chuan Zou
Yuchi Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.780924

4,181 views
18 citations

Review

Published on 10 Dec 2021

Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease

in Renal Pharmacology

Shilu Luo
Ming Yang
Hao Zhao
Yachun Han
Na Jiang
Jinfei Yang
Wei Chen
Chenrui Li
Yan Liu
Chanyue Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2021.768100

5,942 views
15 citations

Original Research

Published on 10 Dec 2021

Maresin 1 Attenuates Lipopolysaccharide-Induced Acute Kidney Injury via Inhibiting NOX4/ROS/NF-κB Pathway

in Renal Pharmacology

Jiameng Li
Zhuyun Zhang
Liya Wang
Luojia Jiang
Zheng Qin
Yuliang Zhao
Baihai Su

Frontiers in Pharmacology

doi 10.3389/fphar.2021.782660

7,487 views
34 citations

Original Research

Published on 09 Dec 2021

Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity

in Renal Pharmacology

Wojciech K. Jankiewicz
Scott D. Barnett
Anna Stavniichuk
Sung Hee Hwang
Bruce D. Hammock
Jawad B. Belayet
A. H. Khan
John D. Imig

Frontiers in Pharmacology

doi 10.3389/fphar.2021.744776

2,366 views
3 citations

Mini Review

Published on 07 Dec 2021

Regulatory B Cell Therapy in Kidney Transplantation

in Renal Pharmacology

Sergio G. Garcia
Noelia Sandoval-Hellín
Marcella Franquesa

Frontiers in Pharmacology

doi 10.3389/fphar.2021.791450

2,456 views
5 citations

Original Research

Published on 07 Dec 2021

Inhibition of Podocytes DPP4 Activity Is a Potential Mechanism of Lobeliae Chinensis Herba in Treating Diabetic Kidney Disease

in Renal Pharmacology

Xinyu Wang
Jiaqing Xiang
Guixiao Huang
Lin Kang
Guangyan Yang
Han Wu
Kewei Jiang
Zhen Liang
Shu Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.779652

3,456 views
8 citations

Original Research

Published on 03 Dec 2021

Knowledge Domain and Emerging Trends in Podocyte Injury Research From 1994 to 2021: A Bibliometric and Visualized Analysis

in Renal Pharmacology

Tongtong Liu
Liping Yang
Huimin Mao
Fang Ma
Yuyang Wang
Yongli Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2021.772386

6,286 views
35 citations

Original Research

Published on 24 Nov 2021

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease

in Renal Pharmacology

Qing Zhang
Yanmei Zhang
Lu Zeng
Guowei Chen
La Zhang
Meifang Liu
Hongqin Sheng
Xiaoxuan Hu
Jingxu Su
Duo Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.757508

5,883 views
25 citations

Systematic Review

Published on 19 Nov 2021

Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis

in Renal Pharmacology

Ying Xu
Yang Chen
Jia Wei Zhao
Chao Li
Amanda Y Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.604017

9,700 views
5 citations

Mini Review

Published on 16 Nov 2021

Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy

in Renal Pharmacology

Wen Li
Jing Sun
Xiaoxi Zhou
Yue Lu
Wenpeng Cui
Lining Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2021.780790

8,868 views
15 citations

Original Research

Published on 15 Nov 2021

Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation

in Renal Pharmacology

Difei Zhang
Bingran Liu
Xina Jie
Jiankun Deng
Zhaoyu Lu
Fuhua Lu
Xusheng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.761572

3,676 views
3 citations

Original Research

Published on 11 Nov 2021

Farrerol Ameliorated Cisplatin-Induced Chronic Kidney Disease Through Mitophagy Induction via Nrf2/PINK1 Pathway

in Renal Pharmacology

Ning Ma
Zhentong wei
Jianqiang Hu
Wenjing Gu
Xinxin Ci

Frontiers in Pharmacology

doi 10.3389/fphar.2021.768700

6,798 views
17 citations

Navigation group

Articles

Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting

Empagliflozin Reduces Renal Hyperfiltration in Response to Uninephrectomy, but Is Not Nephroprotective in UNx/DOCA/Salt Mouse Models

High-Salt Attenuates the Efficacy of Dapagliflozin in Tubular Protection by Impairing Fatty Acid Metabolism in Diabetic Kidney Disease

Immune Characteristics of IgA Nephropathy With Minimal Change Disease

Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats

Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease

Maresin 1 Attenuates Lipopolysaccharide-Induced Acute Kidney Injury via Inhibiting NOX4/ROS/NF-κB Pathway

Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity

Regulatory B Cell Therapy in Kidney Transplantation

Inhibition of Podocytes DPP4 Activity Is a Potential Mechanism of Lobeliae Chinensis Herba in Treating Diabetic Kidney Disease

Knowledge Domain and Emerging Trends in Podocyte Injury Research From 1994 to 2021: A Bibliometric and Visualized Analysis

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease

Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis

Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy

Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation

Farrerol Ameliorated Cisplatin-Induced Chronic Kidney Disease Through Mitophagy Induction via Nrf2/PINK1 Pathway